B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.
about
Recent advances in the field of anti-cancer immunotherapyEffectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaborationPersistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.Simultaneous assessment of rotavirus-specific memory B cells and serological memory after B cell depletion therapy with rituximab.B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancerAnti-non-Gal-specific combination treatment with an anti-idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response.FCGR3A 158V/F polymorphism and response to frontline R-CHOP therapy in diffuse large B-cell lymphoma.De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centersRestrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritisStrategies to circumvent humoral immunity to adeno-associated viral vectors.Characterization of the Highly Prevalent Regulatory CD24hiCD38hi B-Cell Population in Human Cord Blood.Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren's syndrome.Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.B cells participate in tolerance and autoimmunity through cytokine production.Pharmacogenomics of biological treatment in rheumatoid arthritis.Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.B cells and their cytokine activities implications in human diseases.Immunology of idiopathic nephrotic syndrome.Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples.Unintended Immunological Consequences of Biologic Therapy.Anti-CD20 monoclonal antibodies in multiple sclerosis.Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune DiseasesInfluence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia.Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study.Characterization of the B cell response to Leishmania infection after anti-CD20 B cell depletion.CD20+ B cell depletion in systemic autoimmune diseases: common mechanism of inhibition or disease-specific effect on humoral immunity?Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases.CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications.Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.Analysis of Characteristics Similar to Autoimmune Disease in Keloid Patients.Targeting B Cells and Plasma Cells in Autoimmune Diseases.Metformin and Autoimmunity: A "New Deal" of an Old Drug.Ultra-Low Dosage Regimen of Rituximab in Autoimmune Blistering Skin Conditions.B Regulatory Cells: Players in Pregnancy and Early LifeSurface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of LymphocytesSimulation of the Dynamics of Primary Immunodeficiencies in B Cells
P2860
Q26775602-5C7CF8F9-E3EC-4CAF-902C-10A99875CBE7Q31046441-188C10BE-3DCD-4CC3-BED9-4A77B6B24C01Q33411525-2BD73443-69C9-4B2B-A6FC-56703B382BCFQ33599297-68CF6451-C869-41D9-978A-5D97D39B1344Q33721433-139B22F3-57C1-4391-A90B-F0FA5CB12654Q33752292-ED5626D0-9415-4ABB-82A4-ED183A6B005FQ34088194-2695B5D7-A5B0-4A54-AF16-0128BE419A71Q34112037-19CDB751-57A9-47C4-98E2-1748432A1173Q34398374-31E2D2C9-A376-499E-B963-E2DC176C7BBBQ35744377-8ABAC6E2-0755-4BF9-94E7-686F6A6DA6CFQ36398678-7B6FD306-A2F0-42B8-BFB0-6B04FB5E248EQ37683167-4523C320-6B3B-49C7-8ED2-2716AF5C2087Q37690012-C91E0C13-42A7-4552-8F38-BBF8F060B646Q37691074-574A1C11-190F-4134-AC1A-5C126BD1F38CQ38163603-0D57622E-3C0B-4231-99EA-1E077D3F79CBQ38167894-35D5C8FD-4704-42C1-BBC1-8993BB973968Q38262461-99308A5F-3AFF-4A90-BED3-77A0E94F34C9Q38665740-F087CF30-3D5F-4DAC-8D0B-AF55671FE2A0Q38815449-F306E10F-6EC8-4446-91FE-E2FE05C18D77Q38838249-AE1C7363-B951-4226-B96C-5E8026D6EEE2Q38871098-0F43A7F3-3AB1-4C02-B595-B41EF3B8443BQ38975695-5B04DF8B-7A8D-40C2-B94C-37F9168F358EQ39109245-E8464368-EB7B-4921-9359-1B5C07093E7FQ39121590-78F08DC3-150B-4686-9D4D-65625CD97ABAQ40962973-FFEF7074-09C7-4A89-987C-1CA4BEA98A08Q41059758-E1DF9446-5B25-44CC-99D4-0DBDA1C6AC4BQ42356199-034FD202-A776-4D12-BEC8-D3F8E2D6C594Q42372842-CF8FCC2F-DB85-4907-B31B-F1A3172F73DEQ47198384-20CC05C6-FB10-4D10-9107-64AE24FB5873Q47300233-B118056D-5402-49EB-9535-91F16EDA305EQ48098182-F830A8AF-A453-4D45-953C-B9600960EE4DQ49978385-7D368414-7340-4019-8720-13F3D6971F96Q53370794-0325E132-0928-42FF-B1CD-859ECCDE6686Q55234556-CCEB61BF-1B50-4BEC-B7A1-6D48832F4226Q55240881-7123020D-D06A-4223-BC39-F8846119E8CCQ55361376-F448E5BA-B59A-4AB5-9A93-C45D4C5EAEC0Q57159484-A48FF053-FD70-488C-B7F7-471C83B76409Q58726929-01F35285-80F3-4F3E-BD14-003F6731DECBQ58803473-9C7C2E72-F4FA-43C2-BBFD-557229E6F6A2
P2860
B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
B-cell subpopulations in human ...... ti-CD20 monoclonal antibodies.
@en
type
label
B-cell subpopulations in human ...... ti-CD20 monoclonal antibodies.
@en
prefLabel
B-cell subpopulations in human ...... ti-CD20 monoclonal antibodies.
@en
P2860
P921
P356
P1476
B-cell subpopulations in human ...... ti-CD20 monoclonal antibodies.
@en
P2093
Maria J Leandro
P2860
P2888
P356
10.1186/AR3908
P478
15 Suppl 1
P5008
P577
2013-03-25T00:00:00Z
P5875
P6179
1022464417